Process View
The chemical reactions and pathways involving a pyrimidine-containing compound, i.e. any compound that contains pyrimidine or a formal derivative thereof.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "pyrimidine containing compound metabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| NME1 | non-metastatic cells 1, protein (NM23A) expressed in | 0.440 | ||
| ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | 0.100 | ||
| NME3 | non-metastatic cells 3, protein expressed in | 0.068 | ||
| NME4 | non-metastatic cells 4, protein expressed in | 0.043 | ||
| NME2 | non-metastatic cells 2, protein (NM23B) expressed in | 0.040 | Rat | |
| SH3GL3 | SH3-domain GRB2-like 3 | 0.028 | ||
| POLR1C | polymerase (RNA) I polypeptide C, 30kDa | 0.025 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 0.024 | ||
| POLR2H | polymerase (RNA) II (DNA directed) polypeptide H | 0.022 | ||
| SPG21 | spastic paraplegia 21 (autosomal recessive, Mast syndrome) | 0.020 | ||
| NOP56 | NOP56 ribonucleoprotein homolog (yeast) | 0.019 | ||
| PTPRO | protein tyrosine phosphatase, receptor type, O | 0.017 | ||
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) | 0.016 | ||
| UCK2 | uridine-cytidine kinase 2 | 0.016 | ||
| GINS3 | GINS complex subunit 3 (Psf3 homolog) | 0.015 | ||
| RPL38 | ribosomal protein L38 | 0.014 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.012 | ||
| SH3GL2 | SH3-domain GRB2-like 2 | 0.012 | ||
| WDYHV1 | WDYHV motif containing 1 | 0.011 | ||
| ECH1 | enoyl CoA hydratase 1, peroxisomal | 0.011 |